Hoth Therapeutics Files Q1 2025 10-Q
Ticker: HOTH · Form: 10-Q · Filed: May 12, 2025 · CIK: 1711786
| Field | Detail |
|---|---|
| Company | Hoth Therapeutics, Inc. (HOTH) |
| Form Type | 10-Q |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
HOTH filed its 10-Q for Q1 2025. Check financials.
AI Summary
Hoth Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Nevada, is in the pharmaceutical preparations industry. Its principal executive offices are located in New York, NY.
Why It Matters
This filing provides investors with an update on Hoth Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a standard quarterly filing providing financial and operational updates, not indicating immediate high risk.
Key Numbers
- 20250331 — Quarter End Date (Reporting period for the 10-Q)
- 20250512 — Filing Date (Date the 10-Q was submitted to the SEC)
Key Players & Entities
- Hoth Therapeutics, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly Period End Date
- New York, NY (location) — Principal Executive Offices Location
- 1177 Avenue of the Americas (location) — Business Address
- 001-38803 (other) — Commission File Number
FAQ
What is the primary business of Hoth Therapeutics, Inc.?
Hoth Therapeutics, Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
In which state was Hoth Therapeutics, Inc. incorporated?
Hoth Therapeutics, Inc. was incorporated in Nevada.
What is the fiscal year end for Hoth Therapeutics, Inc.?
The fiscal year end for Hoth Therapeutics, Inc. is December 31st.
What is the telephone number for Hoth Therapeutics, Inc.?
The registrant's telephone number, including area code, is (646) 756-2997.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 12, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 12, 2025 regarding Hoth Therapeutics, Inc. (HOTH).